Signaling of soluble FMS-like tyrosine kinase-1 via the gsk-3ß pathway in cytotrophoblast cells

In the study, investigators analyzed the Jada System in 800 patients from October 2020 to April 2022 across 16 hospitals in the United States. Results of the study were presented at the SMFM 43rd Annual Pregnancy Meeting in San Francisco, California.

A single oral dose of azithromycin in women in labor planning vaginal delivery significantly reduced the risk of maternal death and sepsis, according to study results presented at the SMFM 43rd Annual Pregnancy Meeting.

An oral concurrent session at SMFM’s 42nd Annual Pregnancy Meeting highlighted an analysis of pregnancy outcomes after optimal prenatal opioid use disorder care.

An oral presentation at the Society for Maternal-Fetal Medicine’s (SMFM) 42nd Annual Pregnancy Meeting explored possible associations with marijuana use and nausea and vomiting in early pregnancy.

An oral abstract presentation at SMFM’s 42nd Annual Pregnancy Meeting explored cfDNA testing and participants’ knowledge and willingness of genetic data sharing.

Researchers presented a study at the SMFM 42nd Annual Pregnancy Meeting to assess if early gestational diabetes (GDM) screening is associated with improved perinatal outcomes.